In people with type 1 diabetes mellitus, JARDIANCE considerably boosts the hazard of diabetic ketoacidosis, a lifestyle-threatening party, beyond the track record charge. In placebo-controlled trials of sufferers with type one diabetes mellitus, the risk of ketoacidosis was markedly greater in patients who received sodium glucose co-transporter 2 (